Prognostic determinants in patients with stage I uterine papillary serous carcinoma: A 15-year multi-institutional review

International Journal of Gynecological Cancer

Volumn 22, Issue 3, 2012, Pages 417-424

  Growdon, Whitfield B ^a   Rauh Hain, J Jose A ^a,b   Cordon, Adriana ^a   Garrett, Leslie ^a   Schorge, John O ^a   Goodman, Annekathryn ^a   Boruta, David M ^a   Horowitz, Neil S ^b   Del Carmen, Marcela G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endometrial cancer; Stage; Surgery; Uterine papillary serous cancer

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MIXED MULLERIAN TUMOR; OMENTECTOMY; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PELVIS LYMPHADENECTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SECOND CANCER; SURVIVAL TIME; TREATMENT OUTCOME; UTERUS CARCINOMA; UTERUS PAPILLARY SEROUS CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; UTERINE NEOPLASMS;

EID: 84858165666     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31823c6e36     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404-1411. (Pubitemid 30215963)
3. Hendrickson M, Ross J, Eifel P, et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982;6:93-108. (Pubitemid 12108965)
4. Slomovitz BM, Burke TW, Eifel PJ, et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol. 2003;91:463-469. (Pubitemid 38388137)
5. Nicklin JL, Copeland LJ. Endometrial papillary serous carcinoma: patterns of spread and treatment. Clin Obstet Gynecol. 1996;39:686-695. (Pubitemid 26321381)
6. Trope C, Kristensen GB, Abeler VM. Clear-cell and papillary serous cancer: treatment options. Best Pract Res Clin Obstet Gynaecol. 2001;15:433-446. (Pubitemid 32631475)
7. Matthews RP, Hutchinson-Colas J, Maiman M, et al. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. Gynecol Oncol. 1997;65:206-212. (Pubitemid 27216929)
8. Naumann RW. Uterine papillary serous carcinoma: state of the state. Curr Oncol Rep. 2008;10:505-511.
9. Bristow RE, Asrari F, Trimble EL, et al. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (stage I-III) disease. Gynecol Oncol. 2001;81:279-286. (Pubitemid 32424175)
10. Hui P, Kelly M, O'Malley DM, et al. Minimal uterine serous carcinoma: a clinicopathological study of 40 cases. Mod Pathol. 2005;18:75-82. (Pubitemid 40128098)
11. Fader AN, Drake RD, O'Malley DM, et al. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer. 2009;115:2119-2127.
12. Kwon J, Ackerman I, Franssen E. The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys. 2004;59:1439-1445. (Pubitemid 38954066)
13. Lim P, Al Kushi A, Gilks B, et al. Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome. Cancer. 2001;91:752-757. (Pubitemid 32173300)
14. Martinez AA, Weiner S, Podratz K, et al. Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation. Gynecol Oncol. 2003;90:537-546.
15. Mehta N, Yamada SD, Rotmensch J, et al. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 2003;57:1004-1009. (Pubitemid 37324118)
16. Sutton G, Axelrod JH, Bundy BN, et al. Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol. 2006;100:349-354. (Pubitemid 43075268)
17. Huh WK, Powell M, Leath CA 3rd, et al. Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gynecol Oncol. 2003;91:470-475. (Pubitemid 38388138)
18. Fakiris AJ, Moore DH, Reddy SR, et al. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study. Gynecol Oncol. 2005;96:818-823. (Pubitemid 40255507)
19. Dietrich CS 3rd, Modesitt SC, DePriest PD, et al. The efficacy of adjuvant platinum-based chemotherapy in stage I uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2005;99:557-563. (Pubitemid 41686536)
20. Havrilesky LJ, Secord AA, Bae-Jump V, et al. Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007;105:677-682. (Pubitemid 46734192)
21. Thomas MB, Mariani A, Cliby WA, et al. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007;107: 186-189. (Pubitemid 47575712)
22. Kelly MG, O'Malley DM, Hui P, et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol. 2005;98:353-359. (Pubitemid 41169144)
23. Fields AL, Einstein MH, Novetsky AP, et al. Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2008;108:201-206. (Pubitemid 350299448)
24. DuBeshter B, Estler K, Altobelli K, et al. High-dose rate brachytherapy for stage I/II papillary serous or clear cell endometrial cancer. Gynecol Oncol. 2004;94: 383-386. (Pubitemid 39024541)
25. Fader AN, Nagel C, Axtell AE, et al. Stage II uterine papillary serous carcinoma: carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. Gynecol Oncol. 2009;112:558-562.
26. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009;105:109.
27. Boruta DM 2nd, Gehrig PA, Fader AN, et al. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review. Gynecol Oncol. 2009;115:142-153.
28. Carcangiu ML, Tan LK, Chambers JT. Stage IA uterine serous carcinoma: a study of 13 cases. Am J Surg Pathol. 1997;21:1507-1514. (Pubitemid 27528263)
29. Gehrig PA, Groben PA, Fowler WC Jr, et al. Noninvasive papillary serous carcinoma of the endometrium. Obstet Gynecol. 2001;97:153-157. (Pubitemid 32057174)
30. Goff BA, Kato D, Schmidt RA, et al. Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol. 1994;54:264-268. (Pubitemid 24301898)